dockets: FDA-2017-P-7032

Regulatory dockets from Regulations.gov — containers for related documents and comments in a rulemaking proceeding.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id title docket_type last_modified object_id rin dkabstract category subtype keywords program short_title effective_date organization attrs_raw attr_source
FDA-2017-P-7032 FDA Requests that the FDA determine that the drug product, Esomeprazole Magnesium Delayed Release Capsules, USP 10 mg, is suitable for consideration in an Abbreviated New Drug Application Nonrulemaking 2021-08-12T11:31:44Z 0b00006482d843d4   CLOSED - 8/12/2021     ["Citizen Petition", "CDER-OGD", "determine that the drug product", "Esomeprazole Magnesium Delayed Release Capsules", "USP 10 mg, is suitable for consideration", "in an Abbreviated New Drug Application"] CDER-OGD Requests that the FDA determine that the drug product, Esomeprazole Magnesium Delayed Release Capsules, USP 10 mg, is suitable for consideration in an Abbreviated New Drug Application     {"displayProperties": [{"name": "abstract", "label": "General Information", "tooltip": "Describes an agency's specific regulatory action; equivalents: Abstract, Description, Docket Subject, Related To, Summary."}, {"name": "generic", "label": "Docket Item Code", "tooltip": "An agency specific code that identifies the type of document that established the docket (regulatory action)."}, {"name": "program", "label": "Center", "tooltip": "The agency specific program associated with the docket (regulatory action); equivalents: Docket Item Code, Location."}, {"name": "field2", "label": "Docket Status", "tooltip": "Used to Identity that a Docket's Status is Open or Closed"}, {"name": "shortTitle", "label": "Short Title", "tooltip": "A combination of letters and or numbers assigned to an agency's regulatory action for purposes of brevity."}], "keywords": ["Citizen Petition", "CDER-OGD", "determine that the drug product", "Esomeprazole Magnesium Delayed Release Capsules", "USP 10 mg, is suitable for consideration", "in an Abbreviated New Drug Application"], "modifyDate": "2021-08-12T11:31:44Z", "dkAbstract": "CLOSED - 8/12/2021", "agencyId": "FDA", "program": "CDER-OGD", "shortTitle": "Requests that the FDA determine that the drug product, Esomeprazole Magnesium Delayed Release Capsules, USP 10 mg, is suitable for consideration in an Abbreviated New Drug Application", "subType2": null, "title": "Requests that the FDA determine that the drug product, Esomeprazole Magnesium Delayed Release Capsules, USP 10 mg, is suitable for consideration in an Abbreviated New Drug Application", "generic": "P", "field1": null, "docketType": "Nonrulemaking", "petitionNbr": null, "rin": null, "organization": null, "legacyId": null, "subType": null, "category": null, "field2": "CLOSED", "effectiveDate": null, "objectId": "0b00006482d843d4"} single_get

Links from other tables